Drugs and Devices

FDA approves expanded use of Prevnar vaccine

The U.S. Food and Drug Administration (FDA) has approved the use of Prevnar 13, a pneumococcal 13-valent conjugate vaccine, in people 50 years and older. Read More.


Related Articles:

Leave a Reply

Your email address will not be published. Required fields are marked *

 

Shares